- Quote
- Commentary
- Scorecard
- Historical Prices
- Chart
- Stats
- Ratios
- Earnings/Growth Rates
- Statements
- SEC Filings
Recs
Shenanigans.
Recs
the stock its in her lower price and other company with the same prodact without any life saver like psti the stoock need to be like 7-8 dollars
Recs
Their technology seems to work. PLX-PAD is the only drug that heals the heart muscle instead of just prolonging life. Their drug for aplastic anaemia has been given to two people in a tel aviv hospital under Israel's compassion rule for terminal patients and both have survived. Looks like exciting work in their "snake oil". People seem to be scared of any new technology and will wait until they have a product on the market, missing the big run up (or down) during the development.
Recs
Superior technology
Recs
Massively overhyped all over the internet for the last few days.
Recs
biotech has not been as tied to broad market ups and downs.
It is tied to the performance of it's product. PSTI has a product
which has MANY uses,not a one trick poney. It is patented and
is readily repeatable. delivery is simple. the drug stores well in
the typical medical office.
Recs
A very well oriented stem company, with technological aspirations well in the realm of reality, extended their bioreactor capabilities just now,two phase two trials to be released in the near future with nice track record behind them.
Recs
Cell therapeutics derived from placenta. Proprietary bioreactor. Based in Israel.
Recs
needs time and money to develop, but if it is sucsessfull will become a billion + powerhouse.
Recs
Seems to be following that pattern set by Mesoblast only with a much smaller market cap.
RSS Headlines
Fool UK
- Show Me:
-
Outperform
-
Underperform
-
All
- Sort by:
-
Author
-
Recs
-
Date
-
Member Rating
-
Results 1 - 10 of 10